L Prisco1, F Iscra, M Ganau, G Berlot. 1. Department of Perioperative Medicine, Azienda Ospedaliera Universitaria Mista, Ospedali Riuniti di Trieste, Trieste, Italy. sisifo31@hotmail.com
Abstract
AIM: Early hyperglycemia is a feature of traumatic brain injured (TBI) patients. The aim of our study was to analyze the impact of early hyperglycemia on in-ICU mortality in isolated TBI and its correlations with other factors responsible for secondary injury. METHODS: We studied admission values (AV) and worse values in the first 48 hours (WV 48 h) of 112 ICU TBI patients (mortality 29.6%) of blood glucose (BG), base excess (BE), mean arterial pressure (MAP), PaO2/FiO2 ratio and serum hemoglobin (Hb). Predictive strength as the area under the receiver operating curves (AUROC) and correlation between all variables were calculated. RESULTS: Data are expressed as median, 1st-3rd quartile. Both BG AV (147.5, 126-182 mg/dL; AUROC 0.716, P=0.0002) and WV 48 h (156.5, 132-192 mg/dL; AUROC 0.721, P=0.0001) are predictive of mortality. AV and WV 48 h are respectively: PaO2/FiO2 (366.8, 237.2-477.6 vs. 320, 214.4-426; P=0.05), MAP (90, 80-100.5 vs. 75, 66-83 mmHg; P<0.0001) and Hb (11.4, 9.7-13.1 vs. 10.6, 9-12.2 g/dL; P<0.02). BG AV and WV 48 h correlates with: age (r=0.419, P<0.0001 and r=0.489, P<0.0001), PaO2/FiO2 AV (r -0.223, P<0.03 and r -0.236, P<0.02), PaO2/FiO2 WV 48 h (r -0.215, P<0.03 and r -0.279, P<0.005) and MAP WV 48 h (r -0.216, P<0.03 and r -0.261, P<0.007). CONCLUSION: Early hyperglycemia is a major predictor of mortality and correlates with other factors responsible for secondary injury. Early hyperglycemia seems to be a marker of inflammatory reaction responsible for early cardiovascular and respiratory impairment.
AIM: Early hyperglycemia is a feature of traumatic brain injured (TBI) patients. The aim of our study was to analyze the impact of early hyperglycemia on in-ICU mortality in isolated TBI and its correlations with other factors responsible for secondary injury. METHODS: We studied admission values (AV) and worse values in the first 48 hours (WV 48 h) of 112 ICU TBIpatients (mortality 29.6%) of blood glucose (BG), base excess (BE), mean arterial pressure (MAP), PaO2/FiO2 ratio and serum hemoglobin (Hb). Predictive strength as the area under the receiver operating curves (AUROC) and correlation between all variables were calculated. RESULTS: Data are expressed as median, 1st-3rd quartile. Both BG AV (147.5, 126-182 mg/dL; AUROC 0.716, P=0.0002) and WV 48 h (156.5, 132-192 mg/dL; AUROC 0.721, P=0.0001) are predictive of mortality. AV and WV 48 h are respectively: PaO2/FiO2 (366.8, 237.2-477.6 vs. 320, 214.4-426; P=0.05), MAP (90, 80-100.5 vs. 75, 66-83 mmHg; P<0.0001) and Hb (11.4, 9.7-13.1 vs. 10.6, 9-12.2 g/dL; P<0.02). BG AV and WV 48 h correlates with: age (r=0.419, P<0.0001 and r=0.489, P<0.0001), PaO2/FiO2 AV (r -0.223, P<0.03 and r -0.236, P<0.02), PaO2/FiO2 WV 48 h (r -0.215, P<0.03 and r -0.279, P<0.005) and MAP WV 48 h (r -0.216, P<0.03 and r -0.261, P<0.007). CONCLUSION: Early hyperglycemia is a major predictor of mortality and correlates with other factors responsible for secondary injury. Early hyperglycemia seems to be a marker of inflammatory reaction responsible for early cardiovascular and respiratory impairment.
Authors: Mario Forcione; Kamal Makram Yakoub; Antonio Maria Chiarelli; David Perpetuini; Arcangelo Merla; Rosa Sun; Piotr Sawosz; Antonio Belli; David James Davies Journal: Quant Imaging Med Surg Date: 2020-11
Authors: Rebeccah J Katzenberger; Stanislava Chtarbanova; Stacey A Rimkus; Julie A Fischer; Gulpreet Kaur; Jocelyn M Seppala; Laura C Swanson; Jocelyn E Zajac; Barry Ganetzky; David A Wassarman Journal: Elife Date: 2015-03-05 Impact factor: 8.140
Authors: James Tebby; Fiona Lecky; Antoinette Edwards; Tom Jenks; Omar Bouamra; Rozalia Dimitriou; Peter V Giannoudis Journal: BMC Med Date: 2014-07-16 Impact factor: 8.775
Authors: Ata Mahmoodpoor; Hadi Hamishehkar; Kamran Shadvar; Sarvin Sanaie; Afshin Iranpour; Vahid Fattahi Journal: Indian J Crit Care Med Date: 2016-11
Authors: Mario Ganau; Nikolaos Syrmos; Marco Paris; Laura Ganau; Gianfranco K I Ligarotti; Ali Moghaddamjou; Salvatore Chibbaro; Andrea Soddu; Rossano Ambu; Lara Prisco Journal: Medicines (Basel) Date: 2018-02-05